http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0633755-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-005
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
filingDate 1993-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a3289e46d58aa686d7b0332774bbad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d3a3f1484bd1f6fcbf92240d581a2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caad4443fed77189c5ea96bfc1ed5cf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a5817eda33306d03df51e462227a62d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79428aa9e628d0fd06ebbe501ce9fc0c
publicationDate 2000-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0633755-B1
titleOfInvention Systems for cells implants
abstract A method for implanting cells is disclosed which employs a chamber having a wall forming porous boundary between the host and implanted cells. According to the method, a given number of cells (N) is placed within the porous boundary of a given area (A) such that the quantity A/N is less than about 200 mu m2/cell. The porous boundary has a pore size, an ultimate strength, and a metabolic transit value that assures the survival of the cells during the critical ischemic period and afterward.
priorityDate 1992-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127513099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386

Total number of triples: 37.